Page last updated: 2024-08-21

dronabinol and Brain Neoplasms

dronabinol has been researched along with Brain Neoplasms in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (6.25)	18.2507
2000's	9 (56.25)	29.6817
2010's	4 (25.00)	24.3611
2020's	2 (12.50)	2.80

Authors

Authors	Studies
de Paula, BHR; Doherty, GJ	1
Brazil, L; Checketts, D; Jove, M; Miller, S; Sabel, M; Short, SC; Tayo, B; Twelves, C	1
García-Taboada, E; Guzmán, M; Hernández-Tiedra, S; López-Valero, I; Lorente, M; Salazar-Roa, M; Sepúlveda, JM; Torres, S; Velasco, G	1
Barba, M; Dávila, D; García-Taboada, E; Guzmán, M; Hernández-Tiedra, S; López-Valero, I; Lorente, M; Rodríguez-Fornés, F; Saiz-Ladera, C; Salvador-Tormo, N; Sánchez-Gómez, P; Sepúlveda, JM; Torres, S; Velasco, G	1
Allen, D	1
Hanemann, CO; Widmer, M; Zajicek, J	1
Barcia, J; García-Taboada, E; Guzmán, M; Hernández-Tiedra, S; Lorente, M; Rodríguez-Fornés, F; Salazar, M; Torres, S; Velasco, G	1
Abood, ME; Aldape, K; Chan, C; Luu, T; McAllister, SD; Moore, DH; Taft, RJ; Yount, G	1
Boehm, P; Divi, MK; Duntsch, C; Jones, T; Krishnamurthy, M; Moore, BM; Sills, A; Wood, G; Zhou, Q	1
Blázquez, C; Duarte, MJ; Galve-Roperh, I; González-Feria, L; Guzmán, M; Ravina, J; Rosa, MC; Sánchez, C; Velasco, G	1
Amariglio, N; Fisher, T; Galanti, G; Gallily, R; Kventsel, I; Lavie, G; Mechoulam, R; Rechavi, G; Shoham, J; Toren, A	1
Lew, GM	1
Cortés, ML; Galve-Roperh, I; Gómez del Pulgar, T; Guzmán, M; Izquierdo, M; Sánchez, C	1
Giagnoni, G; Massi, P; Parolaro, D; Rubino, T; Spinello, M; Vigano', D; Zagato, E	1
Bénard, J	1
Brune, K; Hinz, B; Pahl, A; Ramer, R	1

Trials

2 trial(s) available for dronabinol and Brain Neoplasms

Article	Year
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma. British journal of cancer, 2021, Volume: 124, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oral Sprays; Precision Medicine; Survival Analysis; Temozolomide; Treatment Outcome	2021
A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. British journal of cancer, 2006, Jul-17, Volume: 95, Issue:2 Topics: Adult; Aged; Biopsy; Brain Neoplasms; Cannabinoid Receptor Antagonists; Cell Proliferation; Disease Progression; Dronabinol; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Receptors, Cannabinoid; Safety; Survival Rate; Treatment Outcome; Tumor Cells, Cultured	2006

Article

Year

A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma.

British journal of cancer, 2021, Volume: 124, Issue:8

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Combinations; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Oral Sprays; Precision Medicine; Survival Analysis; Temozolomide; Treatment Outcome

2021

A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.

British journal of cancer, 2006, Jul-17, Volume: 95, Issue:2

Topics: Adult; Aged; Biopsy; Brain Neoplasms; Cannabinoid Receptor Antagonists; Cell Proliferation; Disease Progression; Dronabinol; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Receptors, Cannabinoid; Safety; Survival Rate; Treatment Outcome; Tumor Cells, Cultured

2006

Other Studies

14 other study(ies) available for dronabinol and Brain Neoplasms

Article	Year
Cannabinoids in glioblastoma multiforme-hype or hope? British journal of cancer, 2021, Volume: 124, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Cell Proliferation; Cell Survival; Clinical Trials, Phase I as Topic; Dronabinol; Drug Combinations; Glioblastoma; Humans; Oral Sprays; Temozolomide; Treatment Outcome	2021
Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma. Biochemical pharmacology, 2018, Volume: 157 Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Carmustine; Cell Line, Tumor; Dronabinol; Glioma; Heterografts; Humans; Male; Mice, Nude; Temozolomide	2018
Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide. Biochemical pharmacology, 2018, Volume: 157 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cannabidiol; Cell Line, Tumor; Dronabinol; Female; Glioblastoma; Humans; Male; Mice, Nude; Neoplastic Stem Cells; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2018
Dronabinol Therapy: Central Nervous System Adverse Events in Adults With Primary Brain Tumors. Clinical journal of oncology nursing, 2019, 02-01, Volume: 23, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Brain Neoplasms; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Nervous System; Psychotropic Drugs; Vomiting	2019
High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells. Journal of neuroscience research, 2008, Nov-01, Volume: 86, Issue:14 Topics: Apoptosis; Blotting, Western; Brain Neoplasms; Cannabinoid Receptor Agonists; Cell Line, Tumor; Cell Proliferation; Dronabinol; Fluorescent Antibody Technique; Glioma; Humans; Receptors, Cannabinoid; Signal Transduction	2008
A combined preclinical therapy of cannabinoids and temozolomide against glioma. Molecular cancer therapeutics, 2011, Volume: 10, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Brain Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cell Survival; Dacarbazine; Dronabinol; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Humans; Mice; Mice, Nude; Random Allocation; Temozolomide; Transfection; Xenograft Model Antitumor Assays	2011
Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells. Journal of neuro-oncology, 2005, Volume: 74, Issue:1 Topics: Benzoxazines; Brain Neoplasms; Cell Death; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Dronabinol; Glioblastoma; Humans; Morpholines; Naphthalenes; Neuroglia; Receptors, Cannabinoid; Tumor Cells, Cultured	2005
Safety and efficacy of a novel cannabinoid chemotherapeutic, KM-233, for the treatment of high-grade glioma. Journal of neuro-oncology, 2006, Volume: 77, Issue:2 Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cannabinoids; Carmustine; Cell Line, Tumor; Dronabinol; Drug Administration Schedule; Glioma; Humans; Inhibitory Concentration 50; Mice; Mice, SCID; Organ Culture Techniques	2006
Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells. Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:6 Topics: Antineoplastic Agents; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Division; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Down-Regulation; Dronabinol; E2F1 Transcription Factor; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thymidylate Synthase; Time Factors; Up-Regulation	2008
Tau protein after delta-9-tetrahydrocannabinol in a human neuroblastoma cell line. General pharmacology, 1996, Volume: 27, Issue:7 Topics: Blotting, Western; Brain Neoplasms; Depression, Chemical; Dronabinol; Electrophoresis, Polyacrylamide Gel; Hallucinogens; Humans; Microtubules; Neuroblastoma; tau Proteins; Tumor Cells, Cultured	1996
Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nature medicine, 2000, Volume: 6, Issue:3 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoxazines; Brain Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Cannabinoids; Ceramides; DNA-Binding Proteins; Dronabinol; Glioma; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Morpholines; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Sphingomyelins; Sphingosine; Tumor Cells, Cultured	2000
Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions. Neuropharmacology, 2000, Apr-27, Volume: 39, Issue:7 Topics: Animals; Autoradiography; Behavior, Animal; Brain; Brain Neoplasms; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dronabinol; Drug Tolerance; Male; Neuroblastoma; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured	2000
[Cannabinoids, among others, send malignant glial tumors to nirvana. . ]. Bulletin du cancer, 2000, Volume: 87, Issue:4 Topics: Animals; Antineoplastic Agents; Benzoxazines; Brain Neoplasms; Dronabinol; Drug Screening Assays, Antitumor; Glioma; Mice; Morpholines; Naphthalenes; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug	2000
R(+)-methanandamide induces cyclooxygenase-2 expression in human neuroglioma cells via a non-cannabinoid receptor-mediated mechanism. Biochemical and biophysical research communications, 2001, Sep-07, Volume: 286, Issue:5 Topics: Analgesics, Non-Narcotic; Arachidonic Acids; Blotting, Western; Brain Neoplasms; Cannabinoid Receptor Modulators; Cell Line; Central Nervous System; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Dronabinol; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Glioma; Humans; Imidazoles; Interleukin-1; Isoenzymes; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pertussis Toxin; Phosphorylation; Piperidines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyridines; Receptors, Cannabinoid; Receptors, Drug; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Virulence Factors, Bordetella	2001